By Will Boggs MD
NEW YORK (Reuters Health) - The new recombinant zoster vaccine (RZV) is more cost-effective than both the zoster vaccine live (ZVL) and no vaccination for preventing herpes zoster and related complications, according to a model study.
By Gene Emery
By Reuters Staff
NEW YORK (Reuters Health) - Exogenous testosterone increases the risk of acne on the chest and abdomen in transgender men, new research shows.
By Marilynn Larkin
NEW YORK (Reuters Health) - Close to 44% of U.S. physicians are burned out, and 15% are depressed and thinking about suicide, according to a survey conducted by Medscape.
By Reuters Staff
NEW YORK (Reuters Health) - Late-life expectancy (LLE) is a better measure of survival benefit with immune-checkpoint inhibitors than is the American Society of Clinical Oncology Value Framework (ASCO-VF), according to a new report.
By Will Boggs MD
NEW YORK (Reuters Health) - The 2019 edition of the American College of Physicians (ACP) ethics manual provides a 6-step approach to resolving ethical dilemmas and adds or expands sections that address emerging issues in 21st century medicine.
By Marilynn Larkin
By Will Boggs MD
NEW YORK (Reuters Health) - Transplanting a combination of noncultured dermal cell suspension (NCDS) and epidermal cell suspension (NCES) provides better responses in patients with vitiligo, compared with NCES transplantation alone, researchers from India report.